Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

<h4>Objectives</h4>Genital herpes simplex virus-2 (HSV-2) shedding in pregnant women in association with neonatal herpes infection has been widely studied but there is limited evidence of its association with pregnancy outcomes.<h4>Methods</h4>In <b>t</b>his retrospective observational study, we included a subgroup of pregnant women who were enrolled in a randomized control behavioural intervention study that was conducted in South Africa in 2008-2010. In pregnancy, women had a HIV rapid test done and a genital swab taken to test for curable STIs and HSV-2 DNA. Subsequent visits were scheduled for 6, 10, 14 weeks and 9 months post-delivery. Pregnancy outcomes were documented at the 6-week or 10-week postpartum visit. Women were treated syndromically for curable STIs.<h4>Results</h4>Among 615 women included in this data analysis, 36.6% (n=225) tested HIV positive and 8.3% (n=51) tested positive for genital HSV-2 shedding during pregnancy. Women <24 years and HIV-1 seropositive women were 1.5 and 2.5 times more likely to test positive for HSV-2 genital shedding respectively. STI treatment records were available for 158/205 (77.1%) women; all 87 women with symptomatic STIs were treated the same day, and 50/71 (70.4%) asymptomatic women received treatment at the subsequent visit. Remaining 21 (29.6%) asymptomatic women did not receive treatment because they failed to return for antenatal follow-up. In a multivariable regression analysis, genital HSV-2 shedding, HIV-1, <i>Neisseria gonorrhoea</i>, <i>Chlamydia trachomatis</i> and <i>Trichomanas vaginalis</i> were not associated with preterm deliveries, still births and low birth weight. However with stratification by treatment for a STI, asymptomatic women who were not treated were 3.3 times more likely to deliver prematurely (33.3%; n=6/18) when compared to women who were treated during pregnancy (13.2%; n=15/114) (p=0.042).<h4>Conclusions</h4>Genital HSV-2 shedding in pregnancy does not appear to alter pregnancy outcomes. Untreated curable STIs (<i>T.vaginalis, C.trachomatis, N.gonorrhoea</i>) were more likely associated with preterm births.

Original publication

DOI

10.1136/sextrans-2017-053113

Type

Journal

Sexually transmitted infections

Publication Date

11/2017

Volume

93

Pages

460 - 466

Addresses

Department of Obstetrics and Gynaecology, University of KwaZulu-Natal, Durban, South Africa.

Keywords

Humans, Herpesvirus 2, Human, Chlamydia Infections, Gonorrhea, Pregnancy Complications, Infectious, Sexually Transmitted Diseases, Herpes Simplex, Herpes Genitalis, HIV Infections, Pregnancy Outcome, Retrospective Studies, Virus Shedding, Pregnancy, Adolescent, Adult, Ambulatory Care Facilities, South Africa, Female, Randomized Controlled Trials as Topic, Young Adult, Point-of-Care Testing